|
|
|
|
Long-term Neurodevelopment of Children Exposed to Maternal Nausea and Vomiting of Pregnancy and Diclectin
(Click the title below to leave the MDLinx Network and go to the Journal's Website) The Journal of Pediatrics, 07/01/09 Print Save in My Library Free Abstract Nulman I et al.- NVP has an enhancing effect on later child outcome.
|
|
|
FDA Rejects GSK Nausea, Vomiting Drug
LINDA A.JOHNSON AP Business Writer TRENTON, N.J. (AP) ' The FDA has rejected GlaxoSmithKline PLC's application to approve an experimental drug for nausea and vomiting. The British drugmaker said Tuesday that it had received a ...
|
|
|
FDA Rejects GlaxoSmithKline Nausea, Vomiting Drug
The U.S.Food and Drug Administration has rejected GlaxoSmithKline PLC's application to approve an experimental drug for nausea and vomiting. The British drugmaker said Tuesday that it had received a 'complete response letter' from the...
|
|
|
Drugs Against Winter Vomiting Disease One Step Closer
The virus that causes winter vomiting disease invades cells by attaching to particular sugar molecules on the surface of the cells.This is the conclusion of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden....
|
|
|
Research and Markets: Nausea and Vomiting Therapy Area Pipeline Report
- Research and Markets (http://www.researchandmarkets.com/research/f8ab12/nausea_and_vomitin) has announced the addition of the 'Nausea and Vomiting Therapy Area Pipeline Report' report to their offering.Life Science Analytics,...
|
|
|
A Step Closer To Drugs Against Winter Vomiting Disease
The virus that causes winter vomiting disease invades cells by attaching to particular sugar molecules on the surface of the cells.This is the conclusion of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden....
|
|
|
What Is Dehydration? What Causes Dehydration?
Dehydration (from the Greek hydor (water)) and the Latin prefix de- (indicating deprivation, removal, and separation) occurs when more water and fluids are exiting the body than are entering the body.With about 75% of the body made up of...
|
|
|
Vomiting - New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. New Phase 3 Study of Tapentadol Immediate...
|
|
|
Acacia Pharma Initiates Phase II Study with APD405 in Post-Operative Nausea and Vomiting
Cambridge, England 8th June 2009: Acacia Pharma, a pharmaceutical company specialising in the development of supportive care drugs, announces the initiation of a Phase II study of its lead compound, APD405, in the prevention of post...
|
|
|
Acacia Pharma Initiates Phase II Study with APD405 in Post-Operative Nausea and Vomiting
Cambridge, England 8th June 2009: Acacia Pharma, a pharmaceutical company specialising in the development of supportive care drugs, announces the initiation of a Phase II study of its lead compound, APD405, in the prevention of post...
|
|
|
Single Dose Palonosetron Prevents Emesis Induced by Chemotherapy in Non Hodgkin's Lymphoma Patients
BERLIN, Germany, June 5 /PRNewswire/ -- - Single Dose Palonosetron is Effective and Safe in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients With Aggressive Non-Hodgkin's Lymphomas who Undergo Moderately...
|
|
|
Pfizer's New Cancer Drug for Dogs Is Mixed News for Rover
Pfizer will launch a new cancer treatment for dogs.The oral drug, Palladia, will help fight mast cell tumors, often seen as skin lumps. This is a good news/bad news situation for dogs. First, older dogs often get fat lumps on their...
|
|
|
What Is A Heart Attack? What Causes A Heart Attack?
Main Category: Heart Disease Also Included In: Cardiovascular / Cardiology email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions: If the heart...
|
|
|
A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
The submission of this NDA marks a significant milestone for the APF530 program, our Biochronomer drug delivery technology and A.P.Pharma as a company, said Ronald J. Prentki, A.P. Pharma's president and chief executive officer. Our...
|
|
|
APF530 Phase 3 Data for Chemotherapy-Induced Nausea and Vomiting to be Presented at American Society of Clinic
The presentation details are as follows: The abstract is available at http://www.abstract.asco.org/AbstView_65_35550.html.About APF530 A.P. Pharma's lead product candidate, APF530, is being developed for the prevention of both acute and...
|
|
|
A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P.Pharma, Inc. (Nasdaq:APPA - News), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and...
|
|
|
A.P. Pharma Submits New Drug Application for APF530 in Chemotherapy-Induced Nausea and Vomiting
Company Website: http:www.appharma.com/REDWOOD CITY, Calif.-- (Business Wire) A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has submitted a New Drug Application (NDA) for its lead product...
|
